PLYMOUTH, Minn.--(BUSINESS WIRE)--ev3 Inc. (NASDAQ:EVVV), in conjunction with its anticipated merger with FoxHollow Technologies, Inc. (NASDAQ:FOXH), today reported preliminary net sales results for its fiscal third quarter ended September 30, 2007. ev3’s net sales in the third quarter of 2007 increased 25% to approximately $65.1 million versus net sales of $51.9 million in the third quarter of 2006. The company’s guidance range for third quarter net sales was $64 to $68 million. This third quarter sales growth reflected a strong contribution from ev3’s cardio peripheral and neurovascular business segments as well as a strong contribution from both domestic and international markets.
